Shanghai Junshi Biosciences Co Ltd (688180) — Cash Flow-to-Debt Ratio
Shanghai Junshi Biosciences Co Ltd (688180) has a Cash Flow-to-Debt Ratio of -0.02x as of December 2025, meaning its operating cash flow of CN¥-142.12 Million could theoretically repay 0% of its total liabilities (CN¥6.16 Billion) in one year. Check cash flow reinvestment rate of Shanghai Junshi Biosciences Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Junshi Biosciences Co Ltd Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Shanghai Junshi Biosciences Co Ltd across 12 annual periods. Also explore 688180 asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai Junshi Biosciences Co Ltd (2014–2025)
Year-by-year debt coverage analysis for Shanghai Junshi Biosciences Co Ltd. For market capitalisation and broader financial context, see Shanghai Junshi Biosciences Co Ltd (688180) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | CN¥-478.14 Million | CN¥6.16 Billion | ▲ +73.9% |
| 2024 | -0.30x | CN¥-1.44 Billion | CN¥4.85 Billion | ▲ +40.3% |
| 2023 | -0.50x | CN¥-2.00 Billion | CN¥4.02 Billion | ▲ +21.9% |
| 2022 | -0.64x | CN¥-1.78 Billion | CN¥2.78 Billion | ▼ -170.3% |
| 2021 | -0.24x | CN¥-641.90 Million | CN¥2.72 Billion | ▲ +65.8% |
| 2020 | -0.69x | CN¥-1.50 Billion | CN¥2.17 Billion | ▲ +16.5% |
| 2019 | -0.83x | CN¥-1.19 Billion | CN¥1.43 Billion | ▼ -51.7% |
| 2018 | -0.55x | CN¥-510.76 Million | CN¥936.18 Million | ▲ +84.2% |
| 2017 | -3.46x | CN¥-347.08 Million | CN¥100.38 Million | ▲ +58.2% |
| 2016 | -8.26x | CN¥-185.21 Million | CN¥22.41 Million | ▼ -42.7% |
| 2015 | -5.79x | CN¥-82.03 Million | CN¥14.16 Million | ▼ -93.2% |
| 2014 | -3.00x | CN¥-39.19 Million | CN¥13.07 Million | — |